{"id":182833,"date":"2017-03-11T07:44:44","date_gmt":"2017-03-11T12:44:44","guid":{"rendered":"http:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/researchers-find-a-gene-that-causes-opitz-c-syndrome-medical-xpress\/"},"modified":"2017-03-11T07:44:44","modified_gmt":"2017-03-11T12:44:44","slug":"researchers-find-a-gene-that-causes-opitz-c-syndrome-medical-xpress","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/gene-medicine\/researchers-find-a-gene-that-causes-opitz-c-syndrome-medical-xpress\/","title":{"rendered":"Researchers find a gene that causes Opitz C syndrome &#8211; Medical Xpress"},"content":{"rendered":"<p><p>March 10, 2017          From left to right, the experts Susana Balcells, Daniel    Grinberg and Roser Urreizti at the Faculty of Biology of the    University of Barcelona    <\/p>\n<p>      Opitz C syndrome is a genetic disease that causes severe      disabilities in patients and has been diagnosed in three      people in the Iberian Peninsula, and 60 people in the world.      A team led by the professors Daniel Grinberg and Susana      Balcells, from the University of Barcelona and the Biomedical      Research Networking Center of Rare Diseases (CIBERER) has now      identified a gene that causes Opitz C syndrome in the only      patient in Catalonia diagnosed with this severe congenital      disease. This new scientific advance is a first step to      discovering the genetic bases of this syndrome which, so far,      has no treatment, prenatal diagnosis or genetic counseling.    <\/p>\n<p>    The new study, published in the journal Scientific    Reports, has the participation of John M. Opitz (University    of Utah, United States), Giovanni Neri (Catholic University of    the Sacred Heart, Italy) and a wide group of experts of the    Center for Genomic Regulation (CRG) and the Department of    Clinical and Molecular Genetics of the University Hospital Vall    d'Hebron (VHIR).  <\/p>\n<p>    Opitz C syndrome: rare but not invisible  <\/p>\n<p>    The genetic bases of this ultra-minority disease, described for    the first time in 1969 by John M. Opitz, are still unknown. It    is generally thought that its origin is caused by the    apparition of dominant -maternally silenced- novo mutations. At    the moment, the diagnose is clinical and it is based on the    symptomatology presented on patients with different degrees    (trigonocephaly, learning disability, psychomotor disability,    etc.) and which, in lots of cases, coincides with similar    minority pathologies such as the syndromes of Schaaf-Yang,    Bohring-Opitz and Prader-Willi.  <\/p>\n<p>    In the new study, the experts described for the first time, the    existence of a novo mutation p.Q638 located in the gene    MAGEL2 of the only diagnosed person with Opitz C syndrome in    Catalonia. Identifying this mutation, found in the Prader-Willi    Region on chromosome 15, widens the knowledge horizons on    genetics and the possibilities for a diagnosis on these rare    diseases.  <\/p>\n<p>    \"The p.Q638* mutation, identified in the gene MAGEL2, coincides    with the one described concurrently and independently in a    patient with Schaaf-Yang syndrome, a new minoritary disease    affecting fifty people in the world. The first cases were    described on a scientific bibliography in 2013 by the team of    Professor Christian Schaaf, from the Baylor College of    Medicine, Houston,\" says Professor Daniel Grinberg, member of    the Institute of Biomedicine of the University of Barcelona    (IBUB), the Research Institute of Sant Joan de Du (IRSJD) and    CIBERER.  <\/p>\n<p>    \"Consequently, from a genetic diagnosis perspective says    DanieL Grinberg- this patient initially diagnosed with Opitz C    in Catalonia would correspond to the group of patients with    Schaaf-Yang syndrome.\"  <\/p>\n<p>    Genetics will define the limits of rare diseases  <\/p>\n<p>    Identifying the genes that cause a disease is a breakpoint to    understand the pathology and set new future therapeutic    approaches that improve the quality of life of the patients. In    the new study, the teams of the UB and the CRG applied    techniques of DNA massive sequencing (exome and genome), a    powerful methodology that allows identifying altered genes in    each patient.  <\/p>\n<p>    According to Susana Balcells, tenured lecturer at the UB and    also member of IBUB and CIBERER, \"what we can see from a    clinical symptomatology view in these kinds of diseases which    are so hard to study and diagnose, is far from the initial    molecular defect that generates the disease.\"  <\/p>\n<p>    \"All these clinical doubts continued Balcells- will be solved    with genetics, which will define the limits of these rare diseases and will ease the scientific    consensus on the diagnosis and genetic causes that create    them.\"  <\/p>\n<p>    According to Luis Serrano, director of CRG, \"projects like this    one show the important role of genomics in the future of    medicine and the way on which we diagnose and treat diseases.    To understand the diseases and offering not only a diagnosis    but also approaches to possible treatments is very relevant in    minority diseases. It is a satisfaction for the CRG to    contribute with our knowledge and advanced technologies in a    project that gives hope to a vulnerable collective,\" concluded    the researcher.  <\/p>\n<p>     Explore further:        Mutations in ASXL3 cause problems similar to Bohring-Opitz    syndrome  <\/p>\n<p>    More information: Roser Urreizti et al. A De Novo    Nonsense Mutation in MAGEL2 in a Patient Initially Diagnosed as    Opitz-C: Similarities Between Schaaf-Yang and Opitz-C    Syndromes, Scientific Reports (2017). DOI:    10.1038\/srep44138<\/p>\n<p>        Mutations which affect the gene ASXL3 cause a novel        syndrome similar to Bohring-Opitz syndrome, finds a study        published in BioMed Central's open access journal Genome        Medicine. This molecular definition distinguishes these ...      <\/p>\n<p>        As so many genome studies do, this study published online        in the journal Nature Genetics began with a single patient        and his parents who were in search of a diagnosis.      <\/p>\n<p>        Scientists at Baylor College of Medicine, Baylor Genetics,        the University of Texas Health Science Center at Houston        and Texas Children's Hospital are combining descriptions of        patients' clinical features with their complex ...      <\/p>\n<p>        The first patient was a mystery. Arriving at Duke six years        ago at the age of three, the youngster had mild        developmental delays and physical characteristics that        included a large body and large head circumference. A        genetic ...      <\/p>\n<p>        A group of researchers from Pakistan, Europe and Singapore        have identified and characterised a previously undiscovered        rare deafness-dystonia syndrome in a family living in a        remote region of Pakistan. The research, published ...      <\/p>\n<p>        A newly discovered mutation in the INPP5K gene, which leads        to short stature, muscle weakness, intellectual disability,        and cataracts, suggests a new type of congenital muscular        dystrophy. The research was published in the ...      <\/p>\n<p>        Recent study out of the University of Ottawa opens door for        new disease therapies in cancer, ALS, Fragile X Syndrome        and others.      <\/p>\n<p>        An unusual case of a rare anemia is opening scientists up        to a new way of thinking about how to adapt and employ        cytokines, messenger molecules of the blood and immune        system, as tools for treatmenttools that are more ...      <\/p>\n<p>        Cells face a daunting task. They have to neatly pack a        several meter-long thread of genetic material into a        nucleus that measures only five micrometers across. This        origami creates spatial interactions between genes and        their ...      <\/p>\n<p>        By the time they turn 50, half of European men have some        degree of hair loss. For many, it will begin far earlier        than that, and yet male pattern baldness is poorly        understood.      <\/p>\n<p>        A component of vertebrate neurons  known as the axon        initial segment (AIS)  that is responsible for regulating        the nerve cell's output has long been thought by scientists        to have evolved relatively recently, and specifically ...      <\/p>\n<p>        Researchers have uncovered new genetic clues to        understanding IgA nephropathy (IgAN), or Berger's disease,        an autoimmune kidney disease and a common cause of kidney        failure. The findings are relevant to IgAN as well as other        ...      <\/p>\n<p>      Please sign      in to add a comment. Registration is free, and takes less      than a minute. Read more    <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read more:<br \/>\n<a target=\"_blank\" href=\"https:\/\/medicalxpress.com\/news\/2017-03-gene-opitz-syndrome.html\" title=\"Researchers find a gene that causes Opitz C syndrome - Medical Xpress\">Researchers find a gene that causes Opitz C syndrome - Medical Xpress<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> March 10, 2017 From left to right, the experts Susana Balcells, Daniel Grinberg and Roser Urreizti at the Faculty of Biology of the University of Barcelona Opitz C syndrome is a genetic disease that causes severe disabilities in patients and has been diagnosed in three people in the Iberian Peninsula, and 60 people in the world. A team led by the professors Daniel Grinberg and Susana Balcells, from the University of Barcelona and the Biomedical Research Networking Center of Rare Diseases (CIBERER) has now identified a gene that causes Opitz C syndrome in the only patient in Catalonia diagnosed with this severe congenital disease.  <a href=\"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/gene-medicine\/researchers-find-a-gene-that-causes-opitz-c-syndrome-medical-xpress\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21],"tags":[],"class_list":["post-182833","post","type-post","status-publish","format-standard","hentry","category-gene-medicine"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/182833"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=182833"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/182833\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=182833"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=182833"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=182833"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}